Skip to main content
Fig. 2 | BMC Urology

Fig. 2

From: Short-term prognosis of low-risk prostate cancer patients is favorable despite the presence of pathological prognostic factors: a retrospective study

Fig. 2

Biochemical recurrence-free survival for the NCCN risk stratification and pathological prognostic factors in all patients. Kaplan–Meier estimates of biochemical recurrence (BCR)-free survival for all risk category patients according to the NCCN risk stratification (a), grade group (GG) (b), lymphovascular invasion (LVI) (c), extraprostatic extension (EPE) (d), surgical margins (SM) (e), seminal vesicle invasion (SVI) (f), intraductal carcinoma of the prostate (IDCP) (g), and pathological assessment of the primary tumor (pT) (h). The log-rank and generalized Wilcoxon tests showed statistically significant differences for all factors examined (log-rank test: SM p = 0.00398, the other factors p < 0.001, generalized Wilcoxon test: SM p = 0.00355, the other factors p < 0.001)

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us